Discontinuation report VIRAMUNE XR
Report ID | 92063 |
Drug Identification Number | 02367289 |
Brand name | VIRAMUNE XR |
Common or Proper name | Viramune XR |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NEVIRAPINE |
Strength(s) | 400MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 30's |
ATC code | J05AG |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-08-20 |
Remaining supply date | 2019-08-20 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | no more supply |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-08-21 | English | Compare |
v2 | 2019-08-21 | French | Compare |
Showing 1 to 2 of 2